TIAA CREF Investment Management’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | $15.4M | Sell |
380,337
-162,705
| -30% | -$6.58M | 0.01% | 825 |
|
|
2018
Q4 | $20.6M | Sell |
543,042
-276,287
| -34% | -$10.5M | 0.02% | 635 |
|
|
2018
Q3 | $32.4M | Buy |
819,329
+326,817
| +66% | +$12.9M | 0.02% | 570 |
|
|
2018
Q2 | $17.3M | Sell |
492,512
-217,033
| -31% | -$7.62M | 0.01% | 817 |
|
|
2018
Q1 | $24.8M | Sell |
709,545
-151,538
| -18% | -$5.3M | 0.02% | 662 |
|
|
2017
Q4 | $29.9M | Sell |
861,083
-49,400
| -5% | -$1.71M | 0.02% | 606 |
|
|
2017
Q3 | $30.8M | Sell |
910,483
-77,320
| -8% | -$2.62M | 0.02% | 591 |
|
|
2017
Q2 | $33.7M | Buy |
987,803
+150,875
| +18% | +$5.14M | 0.02% | 557 |
|
|
2017
Q1 | $26.1M | Buy |
836,928
+297,561
| +55% | +$9.27M | 0.02% | 652 |
|
|
2016
Q4 | $14.7M | Buy |
539,367
+54,381
| +11% | +$1.49M | 0.01% | 896 |
|
|
2016
Q3 | $15.9K | Buy |
484,986
+67,700
| +16% | +$2.23K | 0.01% | 868 |
|
|
2016
Q2 | $12.6M | Buy |
417,286
+18,920
| +5% | +$571K | 0.01% | 936 |
|
|
2016
Q1 | $11.2M | Buy |
398,366
+124,066
| +45% | +$3.49M | 0.01% | 995 |
|
|
2015
Q4 | $9.31M | Sell |
274,300
-38,000
| -12% | -$1.29M | 0.01% | 1113 |
|
|
2015
Q3 | $9.94M | Buy |
312,300
+43,500
| +16% | +$1.38M | 0.01% | 1048 |
|
|
2015
Q2 | $8.56M | Sell |
268,800
-116,000
| -30% | -$3.7M | 0.01% | 1263 |
|
|
2015
Q1 | $13.2M | Sell |
384,800
-3,409,106
| -90% | -$117M | 0.01% | 972 |
|
|
2014
Q4 | $134M | Buy |
3,793,906
+3,071,170
| +425% | +$108M | 0.09% | 247 |
|
|
2014
Q3 | $25.8M | Buy |
722,736
+240,976
| +50% | +$8.61M | 0.02% | 681 |
|
|
2014
Q2 | $17.9M | Sell |
481,760
-49,302
| -9% | -$1.83M | 0.01% | 830 |
|
|
2014
Q1 | $17.2M | Sell |
531,062
-638,518
| -55% | -$20.7M | 0.01% | 842 |
|
|
2013
Q4 | $34.7M | Sell |
1,169,580
-116,564
| -9% | -$3.46M | 0.02% | 596 |
|
|
2013
Q3 | $33.4M | Sell |
1,286,144
-102,398
| -7% | -$2.66M | 0.03% | 583 |
|
|
2013
Q2 | $32.8M | Buy |
+1,388,542
| New | +$32.8M | 0.03% | 567 |
|